David S. Silver
2013
In 2013, David S. Silver earned a total compensation of $922K as President and Chief Operating Officer at Targeted Medical Pharma, a 14% increase compared to previous year.
Compensation breakdown
| Option Awards | $303,291 |
|---|---|
| Salary | $437,750 |
| Other | $181,000 |
| Total | $922,041 |
Silver received $437.8K in salary, accounting for 47% of the total pay in 2013.
Silver also received $303.3K in option awards and $181K in other compensation.
Rankings
In 2013, David S. Silver's compensation ranked 6,990th out of 12,286 executives tracked by ExecPay. In other words, Silver earned more than 43.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,990 out of 12,286 | 43rd |
Division Manufacturing | 2,482 out of 4,612 | 46th |
Major group Chemicals And Allied Products | 754 out of 1,462 | 48th |
Industry group Drugs | 556 out of 1,156 | 52nd |
Industry Pharmaceutical Preparations | 444 out of 890 | 50th |
Source: SEC filing on April 30, 2014.
Silver's colleagues
We found five more compensation records of executives who worked with David S. Silver at Targeted Medical Pharma in 2013.
2013
William Shell
Targeted Medical Pharma
Chief Executive Officer
2013
Kim Giffoni
Targeted Medical Pharma
Executive Vice President of Foreign Sales and Investor Relations
2013
Amir Blachman
Targeted Medical Pharma
VP of Strategy and Operations and Chief Compliance and Ethics Officer
2013
Douglas Gintz
Targeted Medical Pharma
Chief Technology and Information Officer
2013
William Horne
Targeted Medical Pharma